GSE201819
The genetic background shapes the susceptibility to mitochondrial dysfunction and NASH progression
Non-alcoholic steatohepatitis (NASH) is a global health concern without treatment. The challenge in finding effective therapies is due to the lack of good mouse models and the complexity of the disease, characterized by gene–environment interactions. We tested the susceptibility of seven mouse strains to develop NASH. The severity of the clinical phenotypes observed varied widely across strains. PWK/PhJ mice were the most prone to develop hepatic inflammation and the only strain to progress to NASH with extensive fibrosis, while CAST/EiJ mice were completely resistant. Levels of mitochondrial transcripts and proteins as well as mitochondrial function were robustly reduced specifically in the liver of PWK/PhJ mice, suggesting a central role of mitochondrial dysfunction in NASH progression. Importantly, the NASH gene expression profile of PWK/PhJ mice had the highest overlap with the human NASH signature. Our study exposes the limitations of using a single mouse genetic background in metabolic studies and describes a novel NASH mouse model with features of the human NASH. Overall design: RNA sequencing of male livers of 6-8 domesticated (C57BL/6J, DBA/2J, A/J, 129S1/SvlmJ) or wild-derived (CAST/EiJ, PWK/PhJ, WSB/EiJ) inbred mouse strains housed at Thermoneutrality (30°C) and fed with Western Diet or Chow Diet.